Tumor proliferation is a cornerstone of cancer progression and the use of Ki67 is an important aspect, but cell- cycle associated biomarkers, such cyclin D1, cyclin E and p21, considered, as well as prognostic factors, may be associated with a good treatment choice [18,19]. This evidence concerns the gene MKI67 and neoplasm.